Remission of severe, treatment-resistant schizophrenia following adjunctive cannabidiol

Aust N Z J Psychiatry. 2019 Mar;53(3):262. doi: 10.1177/0004867418815982. Epub 2018 Dec 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents*
  • Cannabidiol
  • Combined Modality Therapy
  • Humans
  • Schizophrenia*

Substances

  • Antipsychotic Agents
  • Cannabidiol